Moncef Slaoui resigns from Moderna board, divests $10M in stock

Moncef Slaoui, PhD, the former pharmaceutical executive who was named chief advisor of the government's Operation Warp Speed program, resigned from Moderna's board and will divest his $10 million in stock options, Business Insider reported. 

Dr. Slaoui had sat on the board of Moderna since 2017. Public officials, including Sen. Elizabeth Warren, D-Mass., have said his position with Moderna would have been a conflict of interest in his new role as head of COVID-19 vaccine development if he was incentivized to favor Moderna's vaccine.

Moderna told Business Insider that Dr. Slaoui resigned from the board last week and that he will divest his $10 million in stock options. 

Read the full article here.  

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars